Erratum: Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A [Contraception 2016;93:498–506] (Contraception (2016) 93(6) (498–506) (S0010782416000718) (10.1016/j.contraception.2016.02.024));Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: A 7-year randomized comparative study with the TCu380A

Contraception

Volumn 93, Issue 6, 2016, Pages 498-506

  Rowe, Patrick ^a   Farley, Tim ^a   Peregoudov, Alexandre ^a   Piaggio, Gilda ^b   Boccard, Simone ^a   Landoulsi, Sihem ^c   Meirik, Olav ^d  

^a WORLD BANK   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d Instituto Chileno de Medicina Reproductiva   (Chile)

Author keywords

Levonorgestrel IUD; Mirena ; Paragard ; Randomized trial; Seven years; TCu380A

Indexed keywords

LEVONORGESTREL; CONTRACEPTIVE AGENT;

AMENORRHEA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COPPER INTRAUTERINE DEVICE; DEVICE REMOVAL; DEVICE SAFETY; DRUG EFFICACY; FEMALE; HUMAN; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; VAGINA BLEEDING; VAGINA PAIN; ADULT; ADVERSE EFFECTS; BLEEDING; CHEMICALLY INDUCED; CLINICAL TRIAL; PATIENT SAFETY; PREGNANCY; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UNPLANNED PREGNANCY;

ADULT; AMENORRHEA; CONTRACEPTIVE AGENTS, FEMALE; DEVICE REMOVAL; FEMALE; HEMORRHAGE; HUMANS; INTRAUTERINE DEVICES, COPPER; LEVONORGESTREL; PATIENT SAFETY; PREGNANCY; PREGNANCY, UNPLANNED; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 84959861766     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2016.06.001     Document Type: Erratum

References (29)

1. UNDP/UNFPA/WHO/World Bank, Special Programme of Research, Development, Research Training in Human Reproduction, and Task Force on the Safety and Efficacy of Fertility Regulating Methods The TCu 380 A, TCu 220C, multiload 250 and Nova T IUDs at 3, 5 and 7 years of use - results from three randomized multicenter trials Contraception 42 1990 141 158
2. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, and Development and Research Training in Human Reproduction Long-term reversible contraception: twelve years of experience with the TCu380A and TCu220C Contraception 56 1997 341 352
3. I. Sivin, F. Greenslade, F. Schmidt, and S.N. Waldman The copper T 380 intrauterine device: a summary of scientific data 1992 The Population Council New York
4. P.A. O'Brien, R. Kulier, F.M. Helmerhorst, M. Usher-Patel, and C. d'Arcangues Copper-containing, framed intrauterine devices for contraception: a systematic review of randomized controlled trials Contraception 77 2008 318 327
5. T. Luukkainen, H. Allonen, M. Hankkamaa, P. Holma, T. Pyörälä, J. Terho, and et al. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-months report of a European multicentre study Contraception 36 1987 169 179
6. I. Sivin, J. Stern, J. Diaz, M.M. Diaz, A. Faundes, S. El Mahgoub, and et al. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu380Ag and levonorgestrel 20mcg/day devices Contraception 35 1987 245 255
7. I. Sivin, S. El Mahgoub, T. McCarthy, D.R. Mishell, D. Shoupe, F. Alvarez, and et al. Long-term contraception with the levonorgestrel 20mcg/day (LNg 20) and the coper T 380Ag intra-uterine devices: a five-year randomized study Contraception 42 1990 361 368
8. A.R.A. Aiken, and J. Trussell Recent advances in contraception F1000Prime reports 6 2014 113 10.12703/P6-113 [ http://f1000.com/prime/reports/m/6/113 (Accessed 26 June 2015)]
9. D.L. Eisenberg, C.A. Schreiber, D.K. Turok, S.B. Teal, C.L. Westhoff, D. Mitchell, and et al. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system Contraception 92 2015 10 16
10. Department of Reproductive Health and Research including UNDP/UNFPA/WHO/World Bank, Special Programme of Research, and Development, Research Training in Human Reproduction Annual technical report 2002 2003 World Health Organization Geneva
11. C. Tietze, and S. Lewit Recommended procedures for the statistical evaluation of intrauterine contraception Stud Fam Plann 4 1972 35 42
12. T.M.M. Farley Life-table methods for contraceptive research Stat Med 5 1986 475 489
13. O. Meirik, P.J. Rowe, A. Peregoudov, G. Piaggio, M. Petzold, and for the IUD Research Group at the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an eight year multicenter randomized comparative trial Contraception 80 2009 133 141
14. J. Toivonen, T. Luukkainen, and H. Allonen Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices Obstet Gynecol 77 1991 261 264
15. J.F. Lawless Statistical models and methods for lifetime data 1982 Wiley New York
16. D.R. Cox Regression models and life tables (with discussion) J R Stat Soc Ser B 74 1972 187 220
17. K. Andersson, V. Odlind, and G. Rybo Levonorgestrel-releasing and copper-releasing (Nova T) IUCDs during five years of use: a randomized comparative trial Contraception 49 1994 56 72
18. I. Sivin, J. Stern, E. Coutinho, C.E.R. Mattos, S. El Mahgoub, S. Diaz, and et al. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the copper T380 Ag IUDS Contraception 44 1991 473 480
19. A. Faúndes, F. Alvarez, and J. Díaz A Latin American experience with levonorgestrel IUD Ann Med 25 1993 149 153
20. M. Ronnerdag, and V. Odlind Health effects of long-term use of the intrauterine levonorgestrel releasing system. A follow-up study over 12 years of continuous use Acta Obstet Gynecol Scand 78 1999 716 721
21. M.M. Hidalgo, C. Hidalgo-Regina, M.V. Bahamondes, I. Monteiro, C.A. Petta, and L. Bahamondes Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system Contraception 80 2009 84 89
22. R. French, A.M. Sorhaindo, H.A.A.M. Van Vliet, D.D. Mansour, A.A. Robinson, S. Logan, and et al. Progestogen-releasing intrauterine systems versus other forms of reversible contraceptives for contraception Cochrane Database Syst Rev 3 2004 CD001776 10.1002/14651858.CD001776.pub2
23. K. Heinemann, S. Reed, S. Moehner, and T.D. Minh Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European active surveillance study for intrauterine devices Contraception 91 2015 280 283
24. J.T. Diedrich, T. Madden, Q. Zhao, and J.F. Peipert Long-term utilization and continuation of intrauterine devices Am J Obstet Gynecol 213 2015 822.e1 822.e6
25. T. Backman, I. Rauramo, S. Huhtala, and M. Koskenvuo Pregnancy during the use of levonorgestrel intrauterine system Am J Obstet Gynecol 190 2004 50 54
26. T. Luukkainen, H. Allonen, M. Haukkamaa, P. Lahteenmaki, C.G. Nilsson, and J. Toivonen Five years' experience with levonorgestrel-releasing IUDs Contraception 33 1986 139 148
27. Indian Council of Medical Research, and Task force on IUD Randomized clinical trial with intrauterine devices, (levonorgestrel intrauterine device (LNG), CUT 380Ag, CUT 220C and CUT 200B. A 36-month study Contraception 39 1989 37 52
28. C.G. Nilsson, P.L.A. Lahteenmaki, and T. Luukkainen Ovarian function in amenorrhoeic and menstruating users of a levonorgestrel-releasing intrauterine device Fertil Steril 41 1984 52 55
29. T. Madden, C. McNicholas, Q. Zhao, G.M. Secura, D.L. Eisenberg, and J.F. Peipert Association of age and parity with intrauterine device expulsion Obstet Gynecol 124 2014 718 726